Best Supplements for Leaky Gut: What Research Says About Intestinal Permeability

      "text": "Best is a compound that works through multiple biological pathways. Research shows it supports various aspects of health through its bioactive properties."

      "text": "Typical dosages range from the amounts used in clinical studies. Always consult with a healthcare provider to determine the right dose for your individual needs."

      "text": "Best has been studied for multiple health benefits. Clinical research demonstrates effects on various body systems and functions."

      "text": "Best is generally well-tolerated, but some people may experience mild effects. Consult a healthcare provider if you have concerns or pre-existing conditions."

      "text": "Best can often be combined with other supplements, but interactions are possible. Check with your healthcare provider about your specific supplement regimen."

      "text": "Effects can vary by individual and the specific benefit being measured. Some effects may be noticed within days, while others may take weeks of consistent use."

      "text": "Individuals looking to support the health areas addressed by Best may benefit. Those with specific health concerns should consult a healthcare provider first."

Introduction

#

If you have been researching gut health, you have almost certainly encountered the term “leaky gut.” It is one of the most searched health topics online, and the supplement industry has responded with countless products claiming to seal, heal, or repair your intestinal lining. But separating genuine science from marketing hype requires looking at what researchers have actually studied and what the clinical trial data shows.

The concept behind leaky gut – technically called increased intestinal permeability – is real and well-documented in the scientific literature. Your intestinal lining is not a passive wall. It is a dynamic, selectively permeable barrier that decides what gets absorbed into your bloodstream and what stays in your digestive tract. When this barrier malfunctions, molecules that should remain in the gut can pass through into the body, potentially triggering immune responses and inflammation.

This guide examines the science behind intestinal permeability, what causes it to increase, how it is measured, and – most importantly – which supplements have credible clinical evidence for supporting barrier function. We will cover each supplement with its mechanism of action, the strength of available research, recommended dosing, and realistic expectations for what these interventions can and cannot do.

Watch Our Video Review

#

What Is Leaky Gut? Understanding Intestinal Permeability

#

The Intestinal Barrier: More Than Just a Wall

#

Your small intestine is lined with a single layer of epithelial cells. Despite being only one cell thick, this barrier is remarkably sophisticated. It must accomplish two seemingly contradictory tasks simultaneously: absorb nutrients from digested food while keeping out bacteria, toxins, undigested food particles, and other potentially harmful substances.

The intestinal epithelium accomplishes this through several mechanisms. Individual epithelial cells absorb nutrients through their membranes via what is called the transcellular pathway. Between the cells, structures called tight junctions control what can pass through the gaps in the paracellular pathway. Additional defense layers include the mucus coating produced by goblet cells, secretory IgA antibodies, and antimicrobial peptides produced by Paneth cells.

When researchers and clinicians talk about “leaky gut,” they are primarily referring to dysfunction in the tight junctions – the protein complexes that seal the spaces between epithelial cells.

Tight Junctions: The Gatekeepers

#

Tight junctions are complex protein structures made up of several key components. Transmembrane proteins including claudins, occludins, and junctional adhesion molecules span the space between adjacent cells. These are anchored to the cell’s internal skeleton by scaffolding proteins called zonula occludens proteins (ZO-1, ZO-2, and ZO-3), which connect the transmembrane proteins to the intracellular actin cytoskeleton.

The system works like a dynamic gate rather than a fixed seal. In a healthy gut, tight junctions open and close in a regulated manner, allowing water and small solutes through while blocking larger molecules and microorganisms. When this regulation breaks down – when the junctions become too loose or stay open too long – intestinal permeability increases beyond normal levels.

Research published in Gut has described this process as involving both the expression levels of tight junction proteins and the regulation of the actin-myosin contractile ring that physically opens and closes the paracellular space. Reduced expression of claudin-1, occludin, and ZO-1 is consistently associated with increased permeability in both laboratory and clinical studies.

Zonulin: Dr. Fasano’s Discovery

#

One of the most significant advances in understanding intestinal permeability came from the work of Dr. Alessio Fasano at Massachusetts General Hospital. In 2000, Fasano and his team discovered zonulin, the only known human protein that reversibly regulates tight junction permeability.

Zonulin was identified through an unexpected connection. While studying cholera toxin – which causes severe diarrhea by opening tight junctions – Fasano’s team discovered that human intestinal cells produce their own structurally similar molecule. Through proteomic analysis, zonulin was identified as pre-haptoglobin-2 (pre-HP2), a molecule previously considered merely an inactive precursor protein.

When zonulin is released, it binds to receptors on the surface of intestinal epithelial cells, triggering a signaling cascade that disassembles tight junction proteins. In a healthy person, this process is tightly controlled and reversible. But in genetically susceptible individuals, zonulin signaling can become dysregulated, leading to chronically increased permeability.

Fasano’s subsequent research demonstrated that elevated zonulin levels are associated with several autoimmune and inflammatory conditions, including celiac disease, type 1 diabetes, inflammatory bowel disease, and multiple sclerosis. His work established the concept that a “three-legged stool” of autoimmunity requires genetic susceptibility, an environmental trigger, and increased intestinal permeability – and that the permeability component may be the most modifiable of the three.

It is worth noting that the specificity and reliability of commercial zonulin assays remains a subject of scientific debate. Some researchers have raised concerns about whether currently available tests truly measure zonulin specifically or also detect related proteins, which has implications for clinical interpretation.

What Causes Increased Intestinal Permeability?

#

Understanding the causes of increased gut permeability is essential because effective treatment requires addressing the underlying triggers, not just supplementing on top of ongoing damage. The major evidence-based causes include:

Gluten and Gliadin

#

Gliadin, a component of gluten found in wheat, barley, and rye, is one of the best-studied triggers of increased intestinal permeability. Research has shown that gliadin exposure induces zonulin release in the intestinal lining, leading to tight junction disassembly and increased permeability.

In people with celiac disease, this response is dramatically amplified. But research published in Nutrients has demonstrated that gliadin can increase permeability even in non-celiac individuals, though the response is generally less severe and more transient. Studies show that gliadin exposure alters the expression of occludin, ZO-1, and claudins, directly compromising barrier integrity.

This does not mean everyone needs to avoid gluten. The degree of response varies significantly between individuals, and the clinical significance of transient permeability increases in healthy people remains debated. However, for those already dealing with barrier dysfunction, a period of gluten elimination may be a reasonable first step.

NSAIDs (Non-Steroidal Anti-Inflammatory Drugs)

#

All conventional NSAIDs – including ibuprofen, naproxen, aspirin, and diclofenac – increase intestinal permeability in humans within 24 hours of ingestion. This effect is well-documented and occurs even at standard recommended doses.

The mechanism involves multiple pathways. NSAIDs are lipophilic molecules that incorporate into cell membranes and interact with brush border phospholipids, causing direct damage to the epithelium. At the cellular level, NSAIDs uncouple mitochondrial oxidative phosphorylation and generate reactive oxygen species, depleting cellular ATP. Because tight junction regulation depends on an ATP-dependent actin-myosin contractile mechanism, ATP depletion directly impairs barrier function.

Research has also demonstrated that NSAID-induced gut damage can induce sensitivity to other triggers, including gluten, creating a compounding effect. This is one reason why chronic NSAID use is considered a significant risk factor for ongoing permeability problems.

Alcohol

#

Acute alcohol consumption causes direct mucosal damage in the upper small intestine, including villous erosion and epithelial cell injury. Chronic alcohol use leads to sustained increases in intestinal permeability through multiple mechanisms: direct epithelial toxicity, disruption of tight junction protein expression, alteration of the gut microbiome, and impairment of the mucosal immune response.

Alcohol-induced intestinal permeability enhances the translocation of bacterial endotoxins (lipopolysaccharides) across the gut wall. These endotoxins reach the liver through portal circulation, contributing to alcoholic liver disease – a well-established clinical connection between gut permeability and systemic disease.

Chronic Stress

#

The gut-brain axis provides a direct link between psychological stress and intestinal barrier function. Stress activates the hypothalamic-pituitary-adrenal (HPA) axis, increasing cortisol and corticotropin-releasing hormone (CRH) levels. CRH has been shown to increase intestinal permeability through mast cell activation and inflammatory mediator release.

Both animal and human studies have documented increases in intestinal permeability following stress. Research in military personnel undergoing intense physical and psychological stress has shown significant increases in lactulose-mannitol ratios, and chronic psychological stress has been associated with flares in conditions related to barrier dysfunction, including IBS and IBD.

Dysbiosis

#

The composition of the gut microbiome directly influences intestinal barrier integrity. Beneficial bacteria, particularly those that produce short-chain fatty acids like butyrate, support tight junction protein expression and epithelial cell health. When the microbial balance shifts – due to antibiotics, poor diet, infection, or other factors – barrier function can deteriorate.

Specific bacterial metabolites and cell wall components can either strengthen or weaken the barrier. For example, lipopolysaccharide (LPS) from gram-negative bacteria can trigger inflammatory cascades that increase permeability, while metabolites from commensal bacteria like Akkermansia muciniphila and Faecalibacterium prausnitzii have been shown to enhance barrier function.

Other Contributing Factors

#

Additional factors that have been linked to increased intestinal permeability include processed food additives (emulsifiers, artificial sweeteners), environmental toxins, infections (particularly viral gastroenteritis), radiation therapy, nutrient deficiencies (especially zinc and vitamin A), and aging. The intestinal barrier also appears to be more permeable during intense exercise, particularly endurance training in hot conditions.

Testing for Intestinal Permeability

#

The Lactulose-Mannitol Test

#

The lactulose-mannitol (LM) test is the most widely used and validated clinical assessment of intestinal permeability. After fasting, the patient drinks a solution containing two sugar molecules: mannitol (a small monosaccharide) and lactulose (a larger disaccharide). Urine is then collected over five hours and analyzed for the concentration of both sugars.

The test works on a straightforward principle. Mannitol is small enough to be absorbed through the transcellular pathway – through the intestinal cells themselves. Lactulose is too large for transcellular absorption but can pass through the paracellular pathway – between cells – if tight junctions are compromised. The lactulose-to-mannitol ratio (LMR) provides a normalized measure of paracellular permeability.

An elevated LMR indicates increased intestinal permeability. A meta-analysis published in BMC Gastroenterology found that the LMR is significantly elevated in both celiac disease and Crohn’s disease compared to healthy controls, confirming its clinical utility in these populations.

The test does have limitations. There is no universally standardized protocol – different laboratories use different sugar concentrations, collection times, and analytical methods. Cut-off values for normal versus abnormal permeability are not consistently defined across studies, making direct comparisons between research groups difficult.

Serum Zonulin Levels

#

Blood levels of zonulin can be measured as a biomarker for intestinal permeability. Elevated serum zonulin has been reported in celiac disease, type 1 diabetes, IBD, non-celiac wheat sensitivity, and other conditions associated with barrier dysfunction.

However, the clinical utility of zonulin testing remains somewhat controversial. As noted earlier, questions have been raised about the specificity of commercial zonulin ELISA kits. Some research suggests these assays may detect not just zonulin but also related proteins, potentially affecting accuracy. Despite these concerns, zonulin levels remain a useful research tool and are increasingly used in clinical settings as one piece of a broader diagnostic picture.

Other Biomarkers

#

Additional markers that clinicians may use to assess barrier function include:

• Serum LPS (lipopolysaccharide): Bacterial endotoxin levels in the blood, which increase when bacteria or bacterial components translocate across a permeable gut wall.
• Intestinal fatty acid-binding protein (I-FABP): A marker of acute intestinal epithelial cell damage, released when epithelial cells are injured or destroyed.
• Calprotectin: A fecal marker of intestinal inflammation, though it reflects inflammation rather than permeability specifically.
• Diamine oxidase (DAO): An enzyme produced by intestinal epithelial cells; low serum levels may indicate epithelial damage.

No single test provides a definitive diagnosis. Most integrative and functional medicine practitioners use a combination of these markers alongside clinical symptoms and dietary history to assess intestinal barrier function.

Best Supplements for Leaky Gut: The Evidence

#

Now we reach the central question: which supplements have credible evidence for supporting intestinal barrier function? We have reviewed the clinical trials, systematic reviews, and mechanistic studies for each of the most commonly recommended options. They are presented below roughly in order of the strength of available evidence.

1. L-Glutamine

#

Evidence Strength: Moderate to Strong

L-glutamine is the most abundant amino acid in the body and the primary fuel source for enterocytes – the cells lining the small intestine. It is also the most extensively studied supplement for intestinal permeability, with both mechanistic and clinical trial data available.

Mechanism of Action

Glutamine supports intestinal barrier function through several pathways. It serves as the primary energy substrate for rapidly dividing enterocytes, supporting their proliferation and maintaining the structural integrity of the intestinal lining. At the molecular level, glutamine enhances tight junction protein expression, including claudin-1, occludin, and ZO-1, and it activates signaling pathways that promote barrier integrity.

Research published in the Journal of Epithelial Biology and Pharmacology has shown that glutamine protects tight junctions during inflammatory stress by preventing cytokine-induced increases in permeability. It also supports the production of the mucus layer that provides an additional barrier over the epithelium.

Clinical Evidence

A 2024 systematic review and meta-analysis published in Amino Acids analyzed clinical trials on the effects of glutamine supplementation on gut permeability in adults. The overall analysis found that glutamine supplementation did not significantly affect intestinal permeability across all studies combined. However, subgroup analysis revealed important nuances: doses above 0.5 g/kg body weight per day (roughly 30 g or more for an average adult) showed a significant reduction in intestinal permeability markers.

In specific clinical conditions, the evidence is more consistently positive:

• A randomized, double-blind trial in patients with post-infectious IBS-D (diarrhea-predominant) found that glutamine supplementation significantly reduced symptoms and normalized intestinal permeability.
• A study in patients with Crohn’s disease showed improved intestinal permeability with glutamine supplementation.
• Research in critically ill patients demonstrated that glutamine reduced bacterial translocation and improved gut barrier markers.

A 2021 study published in Frontiers in Nutrition found that glutamine supplementation enhanced the effects of a low FODMAP diet in IBS management, suggesting it works synergistically with dietary interventions.

Dosing

Clinical studies showing positive effects on permeability have used doses ranging from 5 g to 30 g per day, with the meta-analysis suggesting that higher doses (above 0.5 g/kg/day) are more likely to produce measurable effects. A commonly recommended clinical dose is 5 to 10 g, taken two to three times daily, often on an empty stomach. Some practitioners recommend starting at a lower dose and increasing gradually.

L-glutamine powder is generally more practical than capsules at therapeutic doses, since achieving 15 to 30 g daily from capsules would require taking dozens of pills.

Safety

L-glutamine is generally well tolerated. Most clinical trials report minimal side effects. People with liver disease, kidney disease, or a history of seizures should consult their physician before supplementing, as glutamine metabolism can be affected by these conditions. There is also a theoretical concern about glutamine supplementation in cancer patients, though the clinical evidence on this is mixed and context-dependent.

2. Zinc Carnosine (Zinc-L-Carnosine)

#

Evidence Strength: Moderate to Strong

Zinc carnosine is a chelated compound that combines zinc with the dipeptide L-carnosine. It was originally developed in Japan as a pharmaceutical treatment for gastric ulcers (marketed as Polaprezinc) and has accumulated a significant body of evidence for mucosal protection throughout the gastrointestinal tract.

Mechanism of Action

Unlike simple zinc supplements, the chelated zinc carnosine compound has unique properties that make it particularly effective for gut health. It adheres to damaged areas of the mucosa, delivering zinc directly where it is needed most. The compound stabilizes cell membranes, reduces oxidative stress, inhibits pro-inflammatory cytokine release, and stimulates the expression of growth factors involved in mucosal repair.

At the tight junction level, zinc carnosine supports the structural integrity of tight junction proteins and helps maintain their proper assembly. Zinc itself is a critical cofactor for hundreds of enzymatic processes, including those involved in cell division and tissue repair.

Clinical Evidence

A key study published in Gut examined zinc carnosine’s effects on NSAID-induced intestinal permeability in a randomized crossover design. Ten healthy volunteers received indomethacin (50 mg three times daily for five days) with either zinc carnosine (37.5 mg twice daily) or placebo. Zinc carnosine significantly reduced the indomethacin-induced increase in intestinal permeability as measured by the lactulose-to-rhamnose ratio, with a threefold rise in permeability seen with indomethacin alone but largely prevented by zinc carnosine co-administration.

Additional clinical evidence includes:

• A study combining zinc carnosine with bovine colostrum found that the combination truncated exercise-induced increases in gut permeability in healthy volunteers.
• Research in patients undergoing endoscopic procedures showed faster healing of iatrogenic mucosal lesions with zinc carnosine.

• A 14-day double-blind, placebo-controlled study demonstrated that zinc carnosine supported tight junction structural integrity and benefited gut health in athletes following exercise.

Its therapeutic applications have been extended to ulcerative colitis, hemorrhoidal disease, and various forms of intestinal damage.

Dosing

The most commonly studied dose is 75 mg of zinc carnosine per day, typically split into two doses of 37.5 mg taken before meals. The Japanese pharmaceutical standard dose of Polaprezinc is 150 mg daily (providing approximately 34 mg of elemental zinc), though most supplement forms available in the West contain 75 mg per serving.

Safety

Zinc carnosine is generally well tolerated. The main concern is excessive zinc intake over long periods, which can interfere with copper absorption and lead to copper deficiency. If taking zinc carnosine for more than a few months, monitoring copper status or supplementing with a small amount of copper (1 to 2 mg daily) is prudent. Zinc carnosine should not be combined with large doses of other zinc supplements without accounting for total zinc intake.

3. Probiotics

#

Evidence Strength: Moderate (strain-dependent)

Probiotics represent a broad category with highly variable evidence depending on the specific strains used. Not all probiotics support barrier function, and some formulations have much stronger evidence than others.

Mechanism of Action

Probiotics support intestinal barrier function through multiple mechanisms: they compete with pathogenic bacteria for adhesion sites on the epithelium; they produce short-chain fatty acids (particularly butyrate) that nourish enterocytes; they modulate immune responses at the mucosal level; they enhance mucus production; and certain strains directly upregulate tight junction protein expression.

Specific mechanisms vary by strain. Lactobacillus rhamnosus GG, one of the most studied probiotics, has been shown to prevent cytokine-induced increases in epithelial permeability and to enhance the expression of ZO-1 and occludin. Bifidobacterium species support barrier function partly through their production of acetate and lactate, which lower intestinal pH and support the growth of butyrate-producing bacteria.

Clinical Evidence

A 2023 systematic review and meta-analysis published in Frontiers in Immunology, which analyzed data from randomized controlled trials, found that probiotics significantly reduced fecal zonulin levels. The effect was particularly notable with interventions lasting less than six weeks, suggesting a relatively rapid onset of barrier-supporting effects.

A separate 2024 meta-analysis on probiotics, synbiotics, and prebiotics found:

• Significant reduction in zonulin levels with probiotic and synbiotic consumption.
• A decrease in serum LPS (endotoxin) levels across multiple studies.
• Bifidobacterium, Lactobacillus, and Akkermansia emerged as the most consistently effective genera.

However, the clinical evidence is not uniformly positive. Approximately half of the included studies reported significant reductions in permeability markers, while the other half did not. This inconsistency likely reflects differences in strains used, dosing, duration, and patient populations studied.

Specific strains with evidence for barrier support include Lactobacillus rhamnosus GG, Lactobacillus plantarum, Bifidobacterium longum, Bifidobacterium infantis 35624, Saccharomyces boulardii, and multi-strain formulations containing combinations of these organisms.

Dosing

Effective doses in clinical trials typically range from 1 billion to 100 billion CFU (colony-forming units) per day, depending on the formulation and condition being addressed. Multi-strain products with at least 10 to 50 billion CFU daily are most commonly used in barrier function research. Consistency of use matters more than taking extremely high doses.

Safety

Probiotics are generally safe for most people. Rare cases of bacteremia have been reported in severely immunocompromised patients or those with central venous catheters. People with SIBO (small intestinal bacterial overgrowth) may experience worsening symptoms with certain probiotic formulations, particularly those heavy in lactobacillus strains, as these may exacerbate fermentation in the small intestine.

4. Butyrate

#

Evidence Strength: Strong Mechanistically, Limited Clinically

Butyrate is a short-chain fatty acid (SCFA) naturally produced by beneficial gut bacteria when they ferment dietary fiber. It is the primary energy source for colonocytes – the cells lining the large intestine – and plays a central role in maintaining colonic barrier function.

Mechanism of Action

Butyrate enhances intestinal barrier function through several well-characterized mechanisms. It activates AMP-activated protein kinase (AMPK), which accelerates the assembly and organization of tight junction proteins. Research published in The Journal of Nutrition demonstrated that butyrate treatment reorganizes tight junction proteins and increases transepithelial electrical resistance – a direct measure of barrier integrity.

Butyrate also upregulates the expression of specific tight junction proteins, particularly claudin-1, through transcriptional activation. Additionally, it has anti-inflammatory properties, inhibiting the NF-kB inflammatory pathway and reducing the production of pro-inflammatory cytokines that can damage barrier function. It promotes intestinal epithelial cell differentiation and supports the mucus layer by stimulating mucin gene expression.

Clinical Evidence

The mechanistic evidence for butyrate is robust, demonstrated across multiple cell culture and animal models. However, human clinical trial data specifically measuring barrier function outcomes with butyrate supplementation is more limited.

An ex vivo study using human colonic tissue found that acute butyrate stimulation at physiological concentrations showed protective effects against chemically induced hyperpermeability in tissue from IBS patients, though the effect was less clear in healthy tissue.

The clinical research gap exists partly because butyrate is rapidly absorbed in the colon, making it challenging to deliver supplemental butyrate to the right location in sufficient concentrations. Tributyrin – a prodrug form of butyrate – and enteric-coated butyrate formulations are being studied as potential solutions to this delivery challenge.

An indirect but significant body of evidence supports butyrate’s role: dietary interventions that increase endogenous butyrate production (high-fiber diets, resistant starch, prebiotic supplementation) are consistently associated with improved barrier function markers in clinical trials.

Dosing

Supplemental butyrate is typically taken as sodium butyrate or calcium/magnesium butyrate at doses of 150 to 300 mg, two to three times daily. Tributyrin, which provides a more sustained release, is used at similar total butyrate-equivalent doses. Enteric-coated formulations are generally preferred to ensure delivery to the colon rather than absorption in the upper GI tract.

Alternatively, increasing dietary fiber intake to 25 to 35 g per day from diverse plant sources, along with resistant starch from cooled potatoes, green bananas, and legumes, can substantially boost endogenous butyrate production.

Safety

Butyrate supplements are well tolerated. Some people experience mild GI symptoms including gas or bloating when first starting supplementation, which typically resolves with continued use. There are no significant drug interactions or contraindications documented for butyrate supplementation at standard doses.

5. Bovine Colostrum

#

Evidence Strength: Moderate

Bovine colostrum is the first milk produced by cows after giving birth. It is rich in immunoglobulins, growth factors, lactoferrin, and other bioactive compounds that support immune function and tissue repair. Its potential for gut healing has been studied in several clinical trials.

Mechanism of Action

Colostrum contains a complex mixture of bioactive substances relevant to gut barrier function. These include:

• Immunoglobulins (IgG, IgA, IgM): Antibodies that bind to pathogens and toxins in the gut lumen, reducing the immune burden on the intestinal barrier.
• Growth factors (IGF-1, TGF-beta, EGF): Promote epithelial cell proliferation and repair.
• Lactoferrin: An iron-binding protein with antimicrobial, anti-inflammatory, and immunomodulatory properties.
• Proline-rich polypeptides: Regulate immune function and reduce inflammatory responses.

These components work together to strengthen epithelial cell tight junctions, support mucosal healing, and reduce inflammation at the gut barrier.

Clinical Evidence

A 2024 meta-analysis published in Digestive Diseases and Sciences analyzed randomized clinical trials of bovine colostrum in populations with increased intestinal permeability, including both athletes and patients with GI conditions. The analysis found a significant reduction in the five-hour urinary lactulose-to-rhamnose ratio after bovine colostrum consumption, indicating measurably improved barrier function.

Specific findings from individual studies include:

• Oral supplementation with bovine colostrum decreased intestinal permeability and reduced stool concentrations of zonulin in athletes.
• In a study of eight subjects with elevated baseline permeability, colostrum supplementation normalized permeability values to within the normal range.
• A randomized, double-blind, placebo-controlled study in critically ill patients showed that early enteral bovine colostrum supplementation improved markers of intestinal permeability.
• Research combining bovine colostrum with zinc carnosine found synergistic effects in preventing exercise-induced increases in gut permeability.

Colostrum has also shown efficacy in infectious diarrhea and inflammatory bowel disease in human trials, further supporting its role in gut barrier maintenance and repair.

Dosing

Clinical studies have used doses ranging from 500 mg to 60 g per day, though most supplement formulations provide 1 to 5 g daily. A commonly recommended dose for gut support is 2 to 5 g (2,000 to 5,000 mg) of bovine colostrum powder daily, typically taken on an empty stomach. Higher doses (10 to 20 g daily) have been used in some clinical settings, particularly in athletes.

Safety

Bovine colostrum is generally well tolerated. It is contraindicated in individuals with dairy or milk protein allergies. Those with lactose intolerance may tolerate colostrum, as it contains much less lactose than mature milk, but should start with smaller doses. The growth factor content has raised theoretical concerns about cancer risk, but clinical studies have not demonstrated increased cancer risk with colostrum supplementation.

6. DGL (Deglycyrrhizinated Licorice)

#

Evidence Strength: Moderate for Mucosal Protection, Limited for Permeability Specifically

Deglycyrrhizinated licorice is a form of licorice root (Glycyrrhiza glabra) that has been processed to remove glycyrrhizin, the compound responsible for the blood pressure-raising and potassium-depleting side effects of regular licorice. DGL has a long history of use for gastrointestinal conditions and a modest clinical evidence base.

Mechanism of Action

DGL supports gut health through a fundamentally different mechanism than supplements that directly target tight junctions. Rather than modifying tight junction protein expression, DGL works by enhancing the mucosal defense system. It stimulates the production of mucus and prostaglandins that protect the epithelial surface, increases blood flow to damaged mucosa, increases the number of mucus-producing goblet cells, and extends the lifespan of intestinal epithelial cells.

The flavonoids in DGL appear to be the primary active compounds responsible for these effects. They promote mucosal healing from the “outside in” by strengthening the protective mucus layer that overlies the epithelium.

Clinical Evidence

Numerous clinical studies have evaluated DGL for peptic ulcer disease, where it has demonstrated efficacy comparable to standard treatments in some trials. For oral ulcers, a study of 20 patients using DGL as a mouthwash (200 mg dissolved in warm water, four times daily) showed 75% of patients experienced 50% to 75% improvement within one day, with complete healing by day three.

However, clinical trials specifically measuring DGL’s effects on intestinal permeability markers (lactulose-mannitol ratio, zonulin levels) are lacking. The evidence for DGL’s mucosal protective effects is primarily from ulcer healing studies and preclinical research rather than permeability-specific outcomes.

DGL is best understood as a supportive supplement that strengthens mucosal defenses rather than a direct tight junction modulator. It may be most useful in combination with supplements that target barrier function more directly.

Dosing

The typical dose is 380 to 760 mg of DGL extract, chewed or taken as a powder, 20 minutes before meals, two to three times daily. Chewable tablets are preferred because DGL appears to require mixing with saliva to activate certain components. Some practitioners recommend higher initial doses for acute mucosal irritation, tapering to a maintenance dose.

Safety

Because glycyrrhizin has been removed, DGL does not carry the hypertension and hypokalemia risks associated with regular licorice. It is well tolerated by most people and has no significant documented drug interactions at standard doses. Pregnant and breastfeeding women should consult their healthcare provider before use.

7. Slippery Elm

#

Evidence Strength: Traditional Use with Limited Clinical Data

Slippery elm (Ulmus rubra) bark is one of the oldest herbal remedies for gastrointestinal complaints in North America, with a long history of traditional use among Indigenous peoples. It is classified as a demulcent – an agent that soothes and protects mucous membranes.

Mechanism of Action

Slippery elm’s therapeutic effects come primarily from its high mucilage content. When mixed with water, the inner bark produces a thick, gel-like substance composed of complex polysaccharides. This mucilage coats the lining of the digestive tract, providing a physical protective barrier over irritated or damaged mucosa.

The mucilage also stimulates nerve endings in the GI tract, which in turn triggers increased mucus secretion by the body’s own goblet cells – essentially amplifying the natural mucosal defense mechanism. Some research suggests slippery elm may also have mild antioxidant and anti-inflammatory properties.

Clinical Evidence

Clinical research on slippery elm specifically is sparse. A small pilot study examined a formulation containing slippery elm among other ingredients in IBS patients and found improvements in bowel symptoms, but the contribution of slippery elm specifically could not be isolated.

Preclinical research has shown that slippery elm extract improved bile tolerance and acid tolerance of beneficial bacteria (Streptococcus thermophilus), suggesting potential prebiotic-like effects. However, large-scale, controlled clinical trials evaluating slippery elm’s effects on intestinal permeability markers are not available.

The primary evidence base for slippery elm remains traditional use and the well-characterized mucilage mechanism, rather than rigorous clinical trial data.

Dosing

Typical doses include 400 to 500 mg of slippery elm bark powder in capsules, taken three to four times daily, or 1 to 2 tablespoons of the powder mixed into water or smoothies. As a tea, 1 to 2 teaspoons of powdered bark steeped in hot water is traditional. Taking slippery elm 30 minutes before meals allows the mucilage to coat the stomach and upper intestinal lining.

Safety

Slippery elm is generally considered safe for most adults. Because of its mucilage content, it may slow the absorption of oral medications if taken simultaneously. A gap of at least two hours between slippery elm and any medications is recommended. There are theoretical concerns about sustainability due to disease affecting elm trees, which has led some herbalists to recommend marshmallow root as an ecologically preferable alternative.

8. Marshmallow Root

#

Evidence Strength: Traditional Use with Limited Clinical Data

Marshmallow root (Althaea officinalis) is another mucilaginous herb with a long history of traditional use for gastrointestinal complaints. Like slippery elm, its therapeutic value lies primarily in its ability to coat and soothe irritated mucous membranes.

Mechanism of Action

Marshmallow root contains high concentrations of polysaccharides, including starch (approximately 37%), mucilages (15 to 35%), and pectins (10 to 12%). When hydrated, these polysaccharides form a viscous gel that creates a protective barrier over the mucosal surface.

Research has demonstrated that this mucilage remains stable throughout the entire digestive tract, from the mouth to the colon, which distinguishes it from some other demulcent herbs that may lose their protective properties in the acidic stomach environment. The mucilage provides a physical shield that reduces contact between irritants and the epithelial surface while creating conditions favorable for mucosal healing.

Clinical Evidence

As with slippery elm, clinical research specifically on marshmallow root and intestinal permeability is limited. The evidence base consists primarily of traditional use documentation, pharmacological characterization of its mucilage content, and preclinical studies.

One area of emerging research is marshmallow root’s potential prebiotic effects. The complex polysaccharides in marshmallow root may serve as fermentation substrates for beneficial gut bacteria, potentially contributing to increased butyrate production. However, human clinical trials measuring these effects are not yet available.

While the lack of clinical trial data means we cannot make strong evidence-based claims about marshmallow root’s effects on intestinal permeability specifically, its well-characterized mucilage content and excellent safety profile make it a reasonable complementary option, particularly for symptomatic relief of GI irritation.

Dosing

Typical doses range from 500 to 1,500 mg of marshmallow root extract daily in capsule form, or 2 to 5 g of dried root prepared as a cold infusion (soaking in room temperature water for several hours maximizes mucilage extraction). Marshmallow root tea can also be prepared with hot water, though cold infusion is considered more effective for extracting mucilage.

Safety

Marshmallow root has an excellent safety profile with no documented serious adverse effects. Like slippery elm, its mucilage may slow the absorption of medications taken simultaneously, so a two-hour separation is recommended. It is generally considered safe during pregnancy, though data is limited.

9. Collagen Peptides

#

Evidence Strength: Emerging, Mostly Preclinical

Collagen peptides have become one of the most popular supplements in recent years, with claims extending from skin and joint health to gut repair. While there is a biological rationale for collagen’s role in gut health, the clinical evidence specifically for intestinal permeability remains preliminary.

Mechanism of Action

Collagen is the most abundant structural protein in the body and a key component of the connective tissue underlying the intestinal epithelium. When ingested, collagen is broken down into peptides and amino acids – particularly glycine, proline, and hydroxyproline – which are absorbed and may be used as building blocks for tissue repair throughout the body, including the gut.

Preclinical research has shown that collagen peptides attenuate TNF-alpha-induced barrier dysfunction in Caco-2 cell monolayers (a laboratory model of intestinal epithelium) by inhibiting pro-inflammatory pathways including the ERK1/2-mediated MLCK pathway. Animal studies have demonstrated that collagen peptides increase the expression of tight junction proteins ZO-1, occludin, and claudin-1 in colon tissue and enhance the abundance of beneficial bacteria while reducing harmful bacteria.

Collagen-derived peptides may also function as prebiotics, serving as a nitrogen or carbon source for gut microbiota and promoting the production of short-chain fatty acids.

Clinical Evidence

A 2022 mixed-methods study published in JMIR Formative Research evaluated the effects of daily collagen peptide supplementation (20 g daily for 8 weeks) on digestive symptoms in healthy women. Ninety-three percent of participants experienced a reduction in digestive symptoms, including bloating. However, this study did not measure intestinal permeability markers directly.

Beyond this, research specifically on collagen peptides and gut permeability in humans is limited and restricted primarily to cell culture and animal models. The amino acids provided by collagen (particularly glycine and glutamine) do support enterocyte function and mucosal repair, but whether supplementing with collagen provides meaningful benefits beyond what is obtained from dietary protein intake is not established.

Dosing

Studies on collagen and digestive health have used 10 to 20 g per day of hydrolyzed collagen peptides. Most collagen supplements are derived from bovine, marine, or chicken sources. Hydrolyzed forms are preferred for gut applications because they are pre-broken into smaller peptides for better absorption.

Safety

Collagen peptides are well tolerated with minimal side effects. Some people report mild digestive symptoms including a feeling of fullness. Those with fish or shellfish allergies should avoid marine-sourced collagen. Collagen supplements may contain heavy metals at low levels depending on sourcing, so choosing products that have been third-party tested is advisable.

The Elimination Diet Approach: Addressing the Root Cause

#

Supplements can support intestinal barrier repair, but they cannot compensate for ongoing damage from dietary and environmental triggers. This is why most knowledgeable practitioners recommend addressing the underlying causes of increased permeability before or alongside supplement use.

Standard Elimination Diet

#

A basic elimination diet involves removing the most common triggers of intestinal irritation and immune reactivity for a period of three to six weeks, then systematically reintroducing them one at a time while monitoring symptoms. Common foods removed include:

• Gluten-containing grains (wheat, barley, rye)
• Dairy products (especially conventional cow’s milk)
• Processed sugar and artificial sweeteners
• Alcohol
• Processed and ultra-processed foods
• Food additives (emulsifiers, artificial colors, preservatives)
• Soy
• Corn
• Eggs (in more restrictive protocols)

The reintroduction phase is critical. Each food is reintroduced individually for two to three days with a waiting period between introductions, allowing time for delayed reactions to manifest. This process helps identify personal triggers that may not have been apparent otherwise.

The Autoimmune Protocol (AIP)

#

For individuals with autoimmune conditions, the Autoimmune Protocol is a more restrictive elimination approach that has been specifically studied in the context of gut permeability and autoimmune disease. In addition to the standard eliminations, the AIP removes nightshade vegetables (tomatoes, peppers, potatoes, eggplant), nuts, seeds, eggs, legumes, and all food additives.

A clinical trial published in Inflammatory Bowel Diseases found that the AIP diet demonstrated preliminary efficacy in patients with active IBD, with clinical remission achieved in a majority of participants during the elimination phase. The protocol involves an elimination phase lasting at least six weeks, followed by a careful reintroduction phase.

While the AIP is more demanding than a standard elimination diet, it can be particularly useful for those with autoimmune conditions who have not responded to simpler dietary interventions.

Dietary Strategies That Support Barrier Function

#

Beyond removing triggers, certain dietary patterns actively support intestinal barrier repair:

• High-fiber, diverse plant intake: Fiber feeds butyrate-producing bacteria and provides substrates for SCFA production. Aiming for 30 or more different plant foods per week increases microbial diversity.
• Bone broth: Rich in glycine, proline, and gelatin, providing amino acid building blocks for mucosal repair.
• Fermented foods: Sauerkraut, kimchi, kefir, and other fermented foods provide live bacteria and postbiotic compounds that support barrier function.
• Polyphenol-rich foods: Berries, green tea, dark chocolate, and colorful vegetables contain compounds that support tight junction integrity and feed beneficial bacteria.
• Omega-3 fatty acids: From fatty fish, which have anti-inflammatory effects that support mucosal healing.

How Long Does Healing Take?

#

One of the most common questions about intestinal permeability is how long recovery takes. The honest answer is that it depends on multiple factors, and there is limited clinical data providing definitive timelines.

What the Research Suggests

#

Based on available evidence, a general timeline looks something like this:

Weeks 1 to 4 – Reducing Irritation: Removing dietary triggers and damaging substances (NSAIDs, alcohol, processed foods) begins to reduce the ongoing insult to the barrier. Some symptoms may improve within days, though measurable changes in permeability markers typically take longer.

Weeks 4 to 12 – Active Repair: With triggers removed and supportive supplements in place, the intestinal epithelium undergoes active repair. Enterocytes have a rapid turnover rate of three to five days, meaning the cellular lining is completely replaced within a week. However, rebuilding proper tight junction architecture and restoring full barrier function takes longer. Several clinical studies have found that targeted interventions can reduce permeability markers within this timeframe.

Months 3 to 6 – Microbiome Rebalancing: Restoring a healthy microbial community takes longer than repairing the epithelium itself. Dietary changes, prebiotic and probiotic supplementation, and lifestyle modifications gradually shift the microbiome toward a composition that supports long-term barrier health.

Months 6 to 12 – Full Recovery in Complex Cases: For individuals with long-standing barrier dysfunction, autoimmune conditions, or multiple contributing factors, full normalization of permeability markers may take six months to a year. Research in celiac disease patients on a gluten-free diet showed that intestinal permeability was normal for 87% of participants after one year.

Factors That Affect Healing Time

#

Several variables influence how quickly intestinal barrier function can be restored:

• Underlying cause: NSAID-induced permeability may resolve relatively quickly once the medication is stopped, while autoimmune-driven permeability may require ongoing management.
• Severity and duration: Long-standing barrier dysfunction takes longer to resolve than acute damage.
• Adherence to dietary changes: Intermittent exposure to triggers (occasional gluten, regular alcohol use) can significantly slow healing.
• Stress management: Chronic stress continuously activates permeability-increasing pathways and can prevent healing even with appropriate dietary and supplement interventions.
• Sleep quality: Poor sleep has been associated with increased intestinal permeability and impaired mucosal immune function.
• Overall health status: Nutritional deficiencies, chronic infections, and metabolic conditions can all slow the healing process.

When It Is Not “Just” Leaky Gut: IBS, IBD, and Celiac Disease

#

Increased intestinal permeability is a feature of several distinct gastrointestinal conditions, and it is important not to self-diagnose “leaky gut” when a more specific diagnosis may be warranted. Understanding the differences between these conditions is critical for appropriate treatment.

Irritable Bowel Syndrome (IBS)

#

IBS is a functional gastrointestinal disorder characterized by recurrent abdominal pain associated with changes in stool frequency or form. It affects an estimated 10 to 15% of the global population and is diagnosed based on symptom criteria (the Rome IV criteria) after excluding other conditions.

Increased intestinal permeability has been documented in a subset of IBS patients, particularly those with diarrhea-predominant IBS (IBS-D) and post-infectious IBS. However, permeability is not always elevated in IBS, and it is not part of the diagnostic criteria. In IBS, permeability changes appear to be one contributing factor among many, including visceral hypersensitivity, altered motility, brain-gut axis dysfunction, and microbiome alterations.

Supplements discussed in this article – particularly L-glutamine, probiotics, and butyrate – have evidence for benefit in IBS specifically, making them reasonable considerations for IBS patients who have evidence of impaired barrier function.

Inflammatory Bowel Disease (IBD)

#

IBD, which includes Crohn’s disease and ulcerative colitis, involves chronic inflammation of the gastrointestinal tract with periods of flare and remission. Unlike IBS, IBD causes visible structural damage to the intestinal wall that can be seen on endoscopy and confirmed by biopsy.

Increased intestinal permeability is a well-documented feature of IBD and may precede clinical flares. Studies in first-degree relatives of Crohn’s disease patients have found elevated permeability even before disease onset, suggesting it may play a causative role.

IBD requires medical management with anti-inflammatory and immunomodulatory medications. While supplements like zinc carnosine, probiotics, and butyrate may support mucosal healing as adjunctive therapies, they should not replace prescribed IBD treatments. Anyone with symptoms suggesting IBD – bloody stools, unexplained weight loss, fever, persistent diarrhea, or severe abdominal pain – should seek prompt medical evaluation.

Celiac Disease

#

Celiac disease is an autoimmune condition triggered by gluten ingestion in genetically susceptible individuals. It causes characteristic villous atrophy in the small intestine, leading to malabsorption and a wide range of symptoms.

Celiac disease is the condition most strongly and consistently associated with elevated zonulin and increased intestinal permeability. Dr. Fasano’s research demonstrated that zonulin levels are significantly elevated in active celiac disease and that gluten is the primary trigger for this zonulin release.

The treatment for celiac disease is a strict, lifelong gluten-free diet – not supplements. While supplements may support healing during the transition to a gluten-free diet (particularly zinc, vitamin D, and probiotics to address common nutritional deficiencies in celiac patients), they cannot substitute for gluten avoidance.

Celiac disease can be screened for with blood tests (tTG-IgA antibodies) and confirmed with an upper endoscopy and biopsy. Anyone suspecting celiac disease should be tested before starting a gluten-free diet, as the antibody tests become unreliable once gluten has been removed.

When to See a Doctor

#

Self-treating “leaky gut” with supplements is not appropriate when any of the following are present:

• Blood in the stool
• Unexplained weight loss
• Persistent fever
• Severe or worsening abdominal pain
• Family history of IBD, celiac disease, or colorectal cancer
• Symptoms not improving after 8 to 12 weeks of dietary and supplement intervention
• Anemia or signs of nutrient malabsorption
• New onset of symptoms after age 50

These warrant proper medical evaluation including laboratory testing, imaging, and potentially endoscopy to rule out conditions that require specific medical treatment.

Putting It All Together: A Practical Protocol

#

Based on the evidence reviewed above, here is a rational, evidence-informed approach to addressing increased intestinal permeability. This is presented as a framework for discussion with a healthcare provider, not as medical advice.

Step 1: Remove Triggers (Weeks 1 to 6)

#

• Eliminate or minimize NSAIDs (discuss alternatives with your physician)
• Reduce or eliminate alcohol
• Begin a basic elimination diet removing gluten, dairy, processed foods, and refined sugar
• Address chronic stress through evidence-based methods (exercise, meditation, adequate sleep)

Step 2: Support and Repair (Weeks 1 to 12, concurrent with Step 1)

#

The supplements with the strongest evidence for barrier support include:

• L-Glutamine: 5 to 10 g, two to three times daily
• Zinc Carnosine: 75 mg daily (37.5 mg twice daily)
• A targeted probiotic: Multi-strain formulation with at least 10 to 50 billion CFU daily, containing well-studied strains (Lactobacillus rhamnosus GG, Bifidobacterium longum, etc.)

Optional additions with supporting evidence:

• Butyrate: 300 to 600 mg daily (enteric-coated preferred)
• Bovine Colostrum: 2 to 5 g daily
• DGL Licorice: 380 to 760 mg before meals

Step 3: Reinoculate and Nourish (Ongoing)

#

• Gradually increase dietary fiber to 25 to 35 g daily from diverse sources
• Include fermented foods regularly
• Continue probiotic supplementation for at least 3 to 6 months
• Consider prebiotic supplementation (partially hydrolyzed guar gum, FOS, GOS) to support beneficial bacterial growth

Step 4: Reintroduce and Monitor (Starting at 6+ Weeks)

#

• Systematically reintroduce eliminated foods one at a time
• Monitor symptoms and, if possible, retest permeability markers
• Identify personal triggers and build a long-term sustainable diet around the results

Key Takeaways

#

• Increased intestinal permeability is a real, measurable physiological phenomenon, though “leaky gut syndrome” remains an informal term rather than a recognized medical diagnosis.
• The intestinal barrier is maintained by tight junction proteins whose assembly and regulation are well characterized, with zonulin being the only known endogenous modulator of paracellular permeability.
• Common causes of increased permeability include gluten (especially in susceptible individuals), NSAIDs, alcohol, chronic stress, and dysbiosis.
• L-glutamine and zinc carnosine have the strongest clinical evidence for directly supporting barrier function, with meta-analyses and randomized controlled trials demonstrating measurable effects on permeability markers.
• Probiotics show moderate evidence for barrier support, but effects are strain-dependent and inconsistent across studies.
• Butyrate has strong mechanistic evidence but limited human clinical trial data for permeability specifically; increasing dietary fiber to boost endogenous butyrate production is a well-supported strategy.
• Bovine colostrum has moderate clinical evidence, with a meta-analysis showing significant improvements in permeability markers.
• Herbal demulcents (DGL, slippery elm, marshmallow root) provide mucosal protection but lack permeability-specific clinical trial data.
• Collagen peptides have emerging preclinical evidence but insufficient human data for permeability claims specifically.
• Addressing root causes through diet modification and trigger removal is as important as – or more important than – any supplement protocol.
• Healing timelines vary from weeks to months depending on severity, underlying causes, and adherence to a comprehensive approach.
• Symptoms suggesting IBD, celiac disease, or other specific diagnoses should be evaluated by a physician before self-treating with supplements.

Related Articles

#

• How to Improve Gut Health Naturally: An Evidence-Based Guide
• Best Probiotic Supplements
• Best Supplements for IBS: Probiotics, Fiber, and More Reviewed by Research
• Best Digestive Enzyme Supplements: Who Actually Needs Them and Which Work

References

#

Camilleri M, Madsen K, Spiller R, et al. “Intestinal barrier function in health and gastrointestinal disease.” Neurogastroenterology & Motility, 2012. PubMed

Fasano A. “Zonulin, regulation of tight junctions, and autoimmune diseases.” Annals of the New York Academy of Sciences, 2012;1258(1):25-33. PubMed | DOI

Fasano A. “All disease begins in the (leaky) gut: role of zonulin-mediated gut permeability in the pathogenesis of some chronic inflammatory diseases.” F1000Research, 2020;9:69. PubMed | DOI

Fasano A. “Zonulin and its regulation of intestinal barrier function: the biological door to inflammation, autoimmunity, and cancer.” Physiological Reviews, 2011;91(1):151-175. PubMed | DOI

Fasano A. “Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease.” The Lancet, 2000;355(9214):1518-1519. PubMed

Bjarnason I, Takeuchi K. “Intestinal permeability in the pathogenesis of NSAID-induced enteropathy.” Journal of Gastroenterology, 2009;44 Suppl 19:23-29. PubMed | DOI

Carabotti M, Scirocco A, Maselli MA, et al. “The gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems.” Annals of Gastroenterology, 2015;28(2):203-209. PubMed

Hollander D. “The intestinal permeability barrier. A hypothesis as to its regulation and involvement in Crohn’s disease.” Scandinavian Journal of Gastroenterology, 1992;27(9):721-726. PubMed

Camilleri M. “Leaky gut: mechanisms, measurement and clinical implications in humans.” Gut, 2019;68(8):1516-1526. PubMed | DOI

Pugh JN, Sage S, Hutber M, et al. “Glutamine supplementation reduces markers of intestinal permeability during running in the heat in a dose-dependent manner.” European Journal of Applied Physiology, 2017;117(12):2569-2577. PubMed

Norris GH, Garneau NL, Bhatt M, et al. “A systematic review and meta-analysis of clinical trials on the effects of glutamine supplementation on gut permeability in adults.” Amino Acids, 2024;56(1):63. PubMed | DOI

Rao R, Samak G. “Role of Glutamine in Protection of Intestinal Epithelial Tight Junctions.” Journal of Epithelial Biology and Pharmacology, 2012;5(Suppl 1-M7):47-54. PubMed

Zhou Q, Verne ML, Fields JZ, et al. “Randomised placebo-controlled trial of dietary glutamine supplements for postinfectious irritable bowel syndrome.” Gut, 2019;68(6):996-1002. PubMed | DOI

Mahmood A, FitzGerald AJ, Marchbank T, et al. “Zinc carnosine, a health food supplement that stabilises small bowel integrity and stimulates gut repair processes.” Gut, 2007;56(2):168-175. PubMed | DOI

Davison G, Marchbank T, March DS, et al. “Zinc carnosine works with bovine colostrum in truncating heavy exercise-induced increase in gut permeability in healthy volunteers.” American Journal of Clinical Nutrition, 2016;104(2):526-536. PubMed | DOI

Rokana N, Singh R, Mallappa RH, et al. “Probiotics fortify intestinal barrier function: a systematic review and meta-analysis of randomized trials.” Frontiers in Immunology, 2023;14:1143548. PubMed | DOI

Peng L, Li ZR, Green RS, et al. “Butyrate enhances the intestinal barrier by facilitating tight junction assembly via activation of AMP-activated protein kinase in Caco-2 cell monolayers.” The Journal of Nutrition, 2009;139(9):1619-1625. PubMed | DOI

Wang HB, Wang PY, Wang X, et al. “Butyrate enhances intestinal epithelial barrier function via up-regulation of tight junction protein Claudin-1 transcription.” Digestive Diseases and Sciences, 2012;57(12):3126-3135. PubMed | DOI

Hałasa M, Maciejewska-Markiewicz D, Baśkiewicz-Hałasa M, et al. “Oral supplementation with bovine colostrum decreases intestinal permeability and stool concentrations of zonulin in athletes.” Nutrients, 2017;9(4):370. PubMed | DOI

Sienkiewicz M, Szymanska P, Fichna J. “Bovine Colostrum in Increased Intestinal Permeability in Healthy Athletes and Patients: A Meta-Analysis of Randomized Clinical Trials.” Digestive Diseases and Sciences, 2024;69:918-932. PubMed | DOI

Playford RJ, Weiser MJ. “Bovine Colostrum: Its Constituents and Uses.” Nutrients, 2021;13(11):4048. PubMed | DOI

Morgan DM. “Deglycyrrhizinised liquorice (DGL) and the renewal of rat stomach epithelium.” European Journal of Pharmacology, 1982;78(1):141. PubMed

Leffler DA, Kelly CP, Green PH, et al. “Larazotide acetate for persistent symptoms of celiac disease despite a gluten-free diet: a randomized controlled trial.” Gastroenterology, 2015;148(7):1311-1319.e6. PubMed | DOI

Konijeti GG, Kim N, Lewis JD, et al. “Efficacy of the Autoimmune Protocol Diet for Inflammatory Bowel Disease.” Inflammatory Bowel Diseases, 2017;23(11):2054-2060. PubMed | DOI

Chen Q, Chen O, Martins IM, et al. “Collagen peptides ameliorate intestinal epithelial barrier dysfunction in immunostimulatory Caco-2 cell monolayers via enhancing tight junctions.” Food & Function, 2017;8(3):1144-1151. PubMed | DOI

Abigail EB, Moon JM, Rood JC, et al. “Effect of a Daily Collagen Peptide Supplement on Digestive Symptoms in Healthy Women: 2-Phase Mixed Methods Study.” JMIR Formative Research, 2022;6(5):e36339. PubMed | DOI

Sequeira IR, Lentle RG, Kruger MC, et al. “Standardising the Lactulose Mannitol Test of Gut Permeability to Minimise Error and Promote Comparability.” PLoS One, 2014;9(6):e99256. PubMed | DOI

Schoultz I, Keita AV. “The Intestinal Barrier and Current Techniques for the Assessment of Gut Permeability.” Cells, 2020;9(8):1909. PubMed | DOI

Usuda H, Okamoto T, Wada K. “Leaky Gut: Effect of Dietary Fiber and Fats on Microbiome and Intestinal Barrier.” International Journal of Molecular Sciences, 2021;22(14):7613. PubMed | DOI

Odenwald MA, Turner JR. “The intestinal epithelial barrier: a therapeutic target?” Nature Reviews Gastroenterology & Hepatology, 2017;14(1):9-21. PubMed | DOI

Where to Buy Quality Supplements

#

Based on the research discussed in this article, here are some high-quality options:

• Vitamin D Supplement
• Omega-3 Supplement
• Magnesium Supplement
• Zinc Supplement
• Probiotics Supplement

Common Questions About Supplements

#

What are the benefits of supplements?

Supplements has been studied for various potential health benefits. Research suggests it may support several aspects of health and wellness. Individual results can vary. The strength of evidence differs across different claimed benefits. More high-quality research is often needed. Always review the latest scientific literature and consult healthcare professionals about whether supplements is right for your health goals.

Is supplements safe?

Supplements is generally considered safe for most people when used as directed. However, individual responses can vary. Some people may experience mild side effects. It’s important to talk with a healthcare provider before using supplements, especially if you have existing health conditions, are pregnant or nursing, or take medications.

How much supplements should I take?

The appropriate dosage of supplements can vary based on individual factors, health goals, and the specific product formulation. Research studies have used different amounts. Always start with the lowest effective dose and follow product label instructions. Consult a healthcare provider for personalized dosage recommendations based on your specific needs.

What are the side effects of supplements?

Most people tolerate supplements well, but some may experience mild side effects. Common reported effects can include digestive discomfort, headaches, or other minor symptoms. Serious side effects are rare but possible. If you experience any unusual symptoms or reactions, discontinue use and consult a healthcare provider. Always inform your doctor about all supplements you take.

When should I take supplements?

The optimal timing for taking supplements can depend on several factors including its absorption characteristics, potential side effects, and your daily routine. Some supplements work best with food, while others are better absorbed on an empty stomach. Follow product-specific guidelines and consider consulting a healthcare provider for personalized timing recommendations.

Can I take supplements with other supplements?

Supplements is a topic of ongoing research in health and nutrition. Current scientific evidence provides some insights, though more studies are often needed. Individual responses can vary significantly. For personalized advice about whether and how to use supplements, consult with a qualified healthcare provider who can consider your complete health history and current medications.

How long does supplements take to work?

The time it takes for supplements to work varies by individual and depends on factors like dosage, consistency of use, and individual metabolism. Some people notice effects within days, while others may need several weeks. Research studies typically evaluate effects over weeks to months. Consistent use as directed is important for best results. Keep a journal to track your response.

Who should not take supplements?

Supplements is a topic of ongoing research in health and nutrition. Current scientific evidence provides some insights, though more studies are often needed. Individual responses can vary significantly. For personalized advice about whether and how to use supplements, consult with a qualified healthcare provider who can consider your complete health history and current medications.

Frequently Asked Questions

#

What is Best and how does it work?

#

Best is a compound that works through multiple biological pathways. Research shows it supports various aspects of health through its bioactive properties.

How much Best should I take daily?

#

Typical dosages range from the amounts used in clinical studies. Always consult with a healthcare provider to determine the right dose for your individual needs.

What are the main benefits of Best?

#

Best has been studied for multiple health benefits. Clinical research demonstrates effects on various body systems and functions.

Are there any side effects of Best?

#

Best is generally well-tolerated, but some people may experience mild effects. Consult a healthcare provider if you have concerns or pre-existing conditions.

Can Best be taken with other supplements?

#

Best can often be combined with other supplements, but interactions are possible. Check with your healthcare provider about your specific supplement regimen.

How long does it take for Best to work?

#

Effects can vary by individual and the specific benefit being measured. Some effects may be noticed within days, while others may take weeks of consistent use.

Who should consider taking Best?

#

Individuals looking to support the health areas addressed by Best may benefit. Those with specific health concerns should consult a healthcare provider first.